FDA approves Gamifant ® (emapalumab-lzsg) as first-ever treatment for adults and children with Macrophage Activation Syndrome in Still's disease

3 months ago 11
Read Entire Article
  1. Homepage
  2. Finance
  3. FDA approves Gamifant ® (emapalumab-lzsg) as first-ever treatment for adults and children with Macrophage Activation Syndrome in Still's disease

Related

Chrysos FY25 slides reveal 80% EBITDA growth, ambitious FY26 guidance

Chrysos FY25 slides reveal 80% EBITDA growth, ambitious FY26...

6 minutes ago 0
Zelenskiy says Ukrainian troops advance in Zaporizhzhia region

Zelenskiy says Ukrainian troops advance in Zaporizhzhia regi...

1 hour ago 0
USTR says China 'deferred' when US reached out for phone call after export controls expansion

USTR says China 'deferred' when US reached out for phone cal...

2 hours ago 0

Trending

1. saints coach
2. cameron dicker
3. jakobi meyers
4. jordan love stats
5. matlock season 2
6. baker mayfield stats
7. colts
8. zoe saldana
9. nate landman
10. lax flights grounded

Popular

College football by the odds: Vegas picks and preview of Ohio State vs. Notre Dame

College football by the odds: Vegas picks and preview of Ohi...

8 months ago 579
What is Tren de Aragua, the Venezuelan gang targeted by Trump?

What is Tren de Aragua, the Venezuelan gang targeted by Trum...

6 months ago 365
What to do in Las Vegas this week: January 2-8

What to do in Las Vegas this week: January 2-8

9 months ago 261
Taiwan slightly cuts 2025 GDP growth outlook amid Trump tariffs concern

Taiwan slightly cuts 2025 GDP growth outlook amid Trump tari...

7 months ago 251
Australian whose blood saved 2.4 million babies dies

Australian whose blood saved 2.4 million babies dies

7 months ago 224
English (US) English (US) ·
About Us · Contact Us · Terms & Conditions ·

© Sincity Press 2025. All rights are reserved